Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma

By K. Jażdżewski, Elizabeth L. Murray, K. Franssila, B. Jarzab, Daniel R Schoenberg, A. de la Chapelle. Proceedings of the National Academy of Sciences of the United States of America, 2008

864 citations recorded by the source corpus.

Although papillary thyroid carcinoma (PTC) displays strong heritability, no predisposing germ-line mutations have been found. We show that a common G/C polymorphism (rs2910164) within the pre-miR-146a sequence reduced the amount of pre- and mature miR-146a from the C allele 1.9- and 1.8-fold, respectively, compared with the G allele. This is matched by a similar decrease in the amount of each pre-miR generated from the corresponding pri-miR-146a in an in vitro processing reaction. The C allele also interfered with the binding of a nuclear factor to pre-miR-146a. The reduction in miR-146a led to less efficient inhibition of target genes involved in the Toll-like receptor and cytokine signaling pathway (TRAF6, IRAK1), and PTC1 (also known as CCDC6 or H4), a gene frequently rearranged with RET proto-oncogene in PTC. In an association study of 608 PTC patients and 901 controls, we found marked differences in genotype distribution of rs2910164 (P = 0.000002), the GC heterozygous state being associated with an increased risk of acquiring PTC (odds ratio = 1.62, P = 0.000007), and both homozygous states protective with odds ratio = 0.42 for the CC genotype (P = 0.003) and odds ratio = 0.69 for the GG genotype (P = 0.0006). Moreover, 4.7% of tumors had undergone somatic mutations of the SNP sequence. Thus, our data suggest that a common polymorphism in pre-miR-146a affects the miR expression, contributes to the genetic predisposition to PTC, and plays a role in the tumorigenesis through somatic mutation. Preliminary evidence suggests that these effects are mediated through target genes whose expression is affected by the SNP status.

Subfields: Cancer Research, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/7858194081988d0209224615f67377d435cfa4d0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

  1. David Baltimore
  2. C. Harris
  3. Anil Sood
  4. Gabriel Lopez-Berestein
  5. M. Cortez
  6. J. Ferdin
  7. C. Bueso-Ramos
  8. George A. Calin

In Molecular Biology

  1. David Baltimore
  2. C. Harris
  3. Anil Sood
  4. Gabriel Lopez-Berestein
  5. C. Bueso-Ramos
  6. M. Cortez
  7. J. Ferdin
  8. George A. Calin

Citations in the corpus